Clinical Trial Update: Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104 [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating the hepatitis B virus synthetic long peptide vaccine ISA104 (phases 1/2) for chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ISA104

Snippet

Sponsor: Erasmus Medical Center | Conditions: Chronic Hepatitis b | Phase 1, Phase 2 | Status: UNKNOWN